Streptococcus pneumoniae serotype 8 capsular polysaccharide–specific B-cell receptor (ST8 CPS-specific BCR)

The Streptococcus pneumoniae serotype 8 capsular polysaccharide–specific B-cell receptor (BCR) is a membrane-bound immunoglobulin complex that serves as the primary recognition unit for the serotype 8 antigen on B lymphocytes (Source 1.3.1). This receptor specifically binds to the unique tetrasaccharide repeating units of the serotype 8 capsule, which is a critical virulence factor and a leading cause of invasive pneumococcal disease (IPD) such as pneumonia and meningitis (Source 1.1.2, 1.4.1). Upon antigen binding, the BCR initiates a downstream signaling cascade involving adaptive immune components like Syk, Bruton's tyrosine kinase (BTK), and Phospholipase C gamma 2 (PLCγ2), which collectively drive B-cell activation, clonal expansion, and differentiation into antibody-secreting plasma cells (Source 1.3.1, 1.4.4). This target is central to the efficacy of pneumococcal vaccines, including the 23-valent polysaccharide vaccine (PPV23) and newer conjugate vaccines like PCV20 and V116, which are designed to stimulate these specific BCRs to produce protective IgG and IgM antibodies (Source 1.2.3, 1.4.1). While pure polysaccharide vaccines induce a T-cell-independent response that is often suboptimal in children and the elderly, conjugate vaccines link the polysaccharide to a carrier protein to recruit T-cell help, thereby enhancing BCR-mediated activation and establishing long-term immunological memory (Source 1.3.2, 1.4.4). Furthermore, the BCR and its secreted antibody products are being investigated as templates for the development of therapeutic monoclonal antibodies to provide passive immunity against severe or antibiotic-resistant serotype 8 infections (Source 1.4.1).

Other names

Serotype 8 pneumococcal B-cell receptorST8-specific BCRAnti-ST8 BCRStreptococcus pneumoniae serotype 8 capsular polysaccharide receptorST8 CPS-BCR complex

Vaccines containing serotype 8 capsular polysaccharide bind to and cross-link specific B-cell receptors (BCRs) on the surface of B cells, initiating an intracellular signaling cascade through the Igα/Igβ complex and downstream kinases such as Syk and BTK, which leads to B-cell activation, proliferation, and differentiation into antibody-secreting plasma cells and memory B cells.